| 158.900 0.200 (0.13%) 07-28 11:10 |
|
| Open: | 159.100 |
| High: | 159.100 |
| Low: | 156.700 |
| Pre. close: | 158.700 |
| Volume: | 10,303 |
| Avg. volume: | 122,930 |
| MA (50): | 160.280 |
| MA (200): | 146.072 |
| Year high: | 173.500 |
| Year low: | 101.900 |
| Market cap: | 13,135(M) |
| EPS: | 10.02 |
| PE ratio: | 15.86 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Mon, 27 Jul 2026
Weekly Recap: Odevixibat Phase III miss and Ipsen revises voting rights - TradingView
Fri, 24 Jul 2026
BlackRock cuts Ipsen stake below 5%, holds 4.95% of capital - Bitget
Wed, 22 Jul 2026
IPN/N Forecast — Price Target — Prediction for 2027 - TradingView
Fri, 10 Jul 2026
Here's Why Ipsen S.A. Just Paid €700M For Memo Therapeutics AG (OTCMKTS:IPSEY) - Seeking Alpha
Tue, 07 Jul 2026
Ipsen - Half year statement - 2026 06 30 - Yahoo Finance
Wed, 01 Jul 2026
In 2nd deal of week, Ipsen buys Memo’s kidney transplant antibody - BioWorld News
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.